Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

Based on available data, most multiple myeloma patients have residual myeloma cells in their autologous hematopoietic progenitor cells (HPC) grafts during collection for autologous stemcell transplant. However, available literature is based on older induction regimens, e.g., adriamycin and dexametha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bone Marrow Transplant
Egile Nagusiak: Tageja, Nishant, Korde, Neha, Kazandjian, Dickran, Manasanch, Elisabet, Bhutani, Manisha, Kwok, Mary, Mailankody, Sham, Yuan, Constance, Stetler-Stevenson, Maryalice, Leitman, Susan F., Sportes, Claude, Landgren, Ola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740327/
https://ncbi.nlm.nih.gov/pubmed/29728700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0170-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak